EGFR and bone metastasis: In the multivariate analysis, five factors were recognized as the independent prognostic factors for OS including EGFR plasma and bone metastasis at baseline, treatment method, new metastasis site and cfDNA (P = 0.044, 0.012, 0.012, 0.003 and 0.004, respectively) (Table 5).